View in EDS HTML Full Text PDF Full Text

Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response

Saved in:
Bibliographic Details
Title: Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response
Authors: Mansilla-Polo, Miguel1,2 (AUTHOR), García-Moronta, Carmen3 (AUTHOR), Fernández-Crehuet, Pablo4 (AUTHOR), Garbayo-Salmons, Patricia5 (AUTHOR), Pons-Benavent, Martí6 (AUTHOR), Aguilar-González, Lucía7 (AUTHOR), Jiménez-Gallo, David7 (AUTHOR), Alcalá-García, Rebeca8 (AUTHOR), Martín-Ezquerra, Gemma9 (AUTHOR), Martorell, Antonio10 (AUTHOR), Mahiques-Santos, Laura11 (AUTHOR), Alfageme-Roldán, Fernando12 (AUTHOR), Escutia-Muñoz, Begoña1,2 (AUTHOR), Sahuquillo-Torralba, Antonio1,2 (AUTHOR), Fayos-Gregori, Rafael1,2 (AUTHOR), Soto-Moreno, Alberto3 (AUTHOR), Sánchez-Gutiérrez, Irene12 (AUTHOR), Botella-Estrada, Rafael1,2,13 (AUTHOR), Vilarrasa, Eva14 (AUTHOR) evilarrasa@santpau.cat, Molina-Leyva, Alejandro3 (AUTHOR) alejandromolinaleyva@gmail.com
Source: Dermatology & Therapy. Nov2025, Vol. 15 Issue 11, p3267-3283. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01521-z